Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Generic Renagel/Renvela Gains Clarity
Go back to Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Generic Renagel/Renvela Gains Clarity| IMPAX LABORATORIES, Inc. (NASDAQ: IPXL) | Delayed: 18.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.30 | 52 Week High | $45.00 | |||
| Open | $0.04 | 52 Week Low | $13.35 | |||
| Day High | $18.30 | P/E | 12.45 | |||
| Day Low | $18.30 | EPS | $1.47 | |||
| Volume | 10,600 | |||||
| Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) | Delayed: 3.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.36 | 52 Week High | $7.80 | |||
| Open | $438.10 | 52 Week Low | $2.80 | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.36 | EPS | $-0.45 | |||
| Volume | 1,132,646 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.72 -0.06 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.78 | 52 Week High | $44.76 | |||
| Open | $43.51 | 52 Week Low | $36.81 | |||
| Day High | $43.80 | P/E | N/A | |||
| Day Low | $43.24 | EPS | $0.00 | |||
| Volume | 2,719,197 | |||||
